My watch list
my.bionity.com  
Login  
NEWS
Current news

Phase III Trial of the Merck and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra Leone

Merck, known as MSD outside the United States and Canada, and NewLink Genetics Corporation, confirmed that the third, late-stage, clinical trial of their Ebola vaccine candidate rVSV-ZEBOV-GP (V920) has been initiated in Sierra Leone. The vaccine candidate was originally developed by the Pu ... more

Aseptika Granted United States Patent for Biomarkers for Respiratory Infection Onset

Aseptika Limited announced that it has been granted a patent in the United States (US) protecting its invention for a test for respiratory infections, designed to be used by patients at home and by clinicians at the bedside of patients in hospitals. This will open up opportunities for the C ... more

Genevac Consolidate Evaporator & Freeze Dryer Operations In Germany

Genevac has announced, as of 1st April 2015, that LMS Consult GmbH (LMS) has been appointed as the exclusive German distributor for its market leading evaporator systems plus the freeze dryer range of its parent company - SP Scientific.For over 30 years - LMS Consulthave successfully sold a ... more

Sun Pharma and the Technion form Research Collaboration to Develop New Class of Oncology Drugs

Sun Pharmaceutical Industries Ltd. and the Technion – Israel institute of technology announced that their respective subsidiaries have entered into an exclusive worldwide research and license agreement. This agreement aims at the development of a joint project, based on new findings by Nobe ... more

Sobi receives orphan drug designation for Elocta in Switzerland

Swedish Orphan Biovitrum AB has received orphan drug designation in Switzerland for its long acting haemophilia drug candidate Elocta (rFVIIIFc) developed for the treatment of haemophilia A. An orphan drug designation is to encourage the development of medicines for rare diseases and provid ... more

Clyde Biosciences secures new investment

Clyde Biosciences Ltd. has announced a £2 million ‘Series A’ investment led by Epidarex Capital, a leading international early-stage life science venture capital fund.  Scottish Enterprise’s investment arm, the Scottish Investment Bank, also participated in the round along with Glasgow Univ ... more

Recipharm makes strategic investment in Synthonics

Recipharm announced that it has made an equity investment in Synthonics Inc and purchased $2.0 million of preferred stock in the company.A further $2.0 million of preferred stock will be purchased upon Synthonics’ achievement of certain milestones, which could be expected during 2016.  In a ... more

A new tool for understanding ALS: Patients' brain cells

Researchers at Johns Hopkins Medicine have transformed skin cells from patients with Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS), into brain cells affected by the progressive, fatal disease and deposited those human-made cells into the first public ALS cell library, enablin ... more

Pharmalink announces positive results in Phase 2b trial of Nefecon

Pharmalink AB announced that the NEFIGAN Trial of Nefecon® for the treatment of primary IgA nephropathy has fully met its primary efficacy endpoint at a planned interim analysis and been stopped early with respect to statistical analysis of the endpoint. The NEFIGAN Trial is a Phase 2b rand ... more

ThromboGenics and VIB launch New Oncology Company

ThromboGenics NV announced the foundation of Oncurious NV, a new oncology company that will develop TB-403 for the treatment of pediatric brain tumors. VIB will become a shareholder alongside ThromboGenics in this new oncology venture. ThromboGenics will be the majority shareholder. TB-403 ... more

All news

Belgian Start-up UgenTec Receives Funding from European Investors

UgenTec, a start-up company based in Belgium that develops laboratory software for automating PCR based DNA analysis, announced that it has received more than €1m in venture capital funding from a group of Belgian investors and an additional €250,000 in research funds from the IWT, a govern ... more

Mummified bodies reveal how tuberculosis ravaged the heart of 18th century Europe

Bodies found in a 200 year-old Hungarian crypt have revealed the secrets of how tuberculosis (TB) took hold in 18th century Europe, according to a research team led by the University of Warwick. A new study published in Nature Communications details how samples taken from naturally mummifie ... more

Trapping and watching motile cells

Optical imaging of highly motile cells or cells in suspension, such as bacterial systems, yeast cells, and immune cells, is a challenging task, in many cases it is just not possible. The human immunodeficiency virus (HIV), for example, can spread very efficiently from an infected T cell to ... more

Rapid and efficient DNA chip technology for testing 14 major types of food borne pathogens

Toshiba Ltd and Kawasaki City Institute for Public Health collaborate in the development of a rapid and efficient DNA chip technology for testing 14 major types of food borne pathogens for applications in hygiene management in food manufacture, pharmaceuticals, and cosmetics. The researcher ... more

MDxHealth's ConfirmMDx Genes Detect Clinically Significant Prostate Cancer

MDxHealth SA announced that data demonstrating the prognostic value of its ConfirmMDx® for Prostate Cancer genes and technology was presented at the ASCO Genitourinary Cancers Symposium 2015.  The data support the ability to predict the presence of clinically significant cancer in biopsy-ne ... more

Technology Partnership between Berthold Technologies & Biametrics

Berthold Technologies has recently established a co-operation with its new technology partner Biametrics GmbH. A spin-off of Tübingen University, Biametrics develops novel solutions for label-free analysis of bio-interactions. The 1λ-Reflectometric Interference Detection (1λ-RIDe) is the mi ... more

Huntingdon Life Sciences and Harlan Laboratories to operate under new brand and name

Huntingdon Life Sciences (HLS) and Harlan Laboratories have announced that the two companies will be rebranded to reflect the new integrated management structure that has been put in place and the broader product and service offerings of the combined organizations. One of the world’s leadin ... more

Healthcare is up for a Revolution with the Rise of Personal Genomic Tests

As the era of personalized medicine dawns on healthcare, the need to understand an individual’s genetic information through genomic testing has risen. This emerging branch of medicine has given birth to multiple companies that provide genetic tests to help end users understand their genetic ... more

The promiscuity of chemical probes discovered

Researchers at IMIM (Hospital del Mar Medical Research Institute) have applied a new computational methodology to anticipate the degree of selectivity of the molecules that are used to study protein functions and reduce the risk of establishing erroneous relations between proteins and disea ... more

Eurofins acquires BioDiagnostics, Inc.

Eurofins Scientific announces the acquisition of BioDiagnostics Inc. (BDI), seed and plant-tissue testing laboratories serving the agricultural industry in the US.Founded in 1996, BDI employs 120 staff at its laboratory in River Falls, WI. BDI offers genetic, seed quality, as well as analyt ... more

All news on bioanalytics

Clyde Biosciences secures new investment

Clyde Biosciences Ltd. has announced a £2 million ‘Series A’ investment led by Epidarex Capital, a leading international early-stage life science venture capital fund.  Scottish Enterprise’s investment arm, the Scottish Investment Bank, also participated in the round along with Glasgow Univ ... more

A new tool for understanding ALS: Patients' brain cells

Researchers at Johns Hopkins Medicine have transformed skin cells from patients with Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS), into brain cells affected by the progressive, fatal disease and deposited those human-made cells into the first public ALS cell library, enablin ... more

ThromboGenics and VIB launch New Oncology Company

ThromboGenics NV announced the foundation of Oncurious NV, a new oncology company that will develop TB-403 for the treatment of pediatric brain tumors. VIB will become a shareholder alongside ThromboGenics in this new oncology venture. ThromboGenics will be the majority shareholder. TB-403 ... more

Merck Appoints Udit Batra to Head Combined Life Science Business

Merck announced that Udit Batra, currently CEO and President of Merck Millipore, has been appointed to lead the combined life science business of Merck Millipore and Sigma-Aldrich once the acquisition of Sigma-Aldrich has been successfully completed. The planned $ 17 billion transaction rem ... more

CryoLife Announces Retirement of Founder and Executive Chairman Steven G. Anderson

CryoLife, Inc. announced that Steven G. Anderson, 76, Executive Chairman of the Board of Directors, has decided to retire effective immediately.  As a result of his retirement, he will step down from all positions with the company and its subsidiaries, including as a member of the Board of ... more

Scientists a step closer to developing renewable propane

Researchers at The University of Manchester have made a significant breakthrough in the development of synthetic pathways that will enable renewable biosynthesis of the gas propane. This research is part of a programme of work aimed at developing the next generation of biofuels.This study p ... more

Omnivorous bacteria can process plastic into food and clean oil-contaminated soils

Back in 1986 scientists from Tomsk State University (TSU) were working on the problems involved in cleaning up oil spills. This research lead to the discovery of oil-eating bacteria. Vladimir Kaluzhin, a senior research associate with the Research Institute for Biology and Biophysics at Tom ... more

FuturaGene’s Eucalyptus Is Approved for Commercial Use in Brazil

The Brazilian National Technical Commission on Biosafety (CTNBio) approved the commercial use of the yield enhanced eucalyptus developed by FuturaGene, a wholly owned subsidiary of Suzano Pulp and Paper. Field experiments conducted since 2006 at various locations in Brazil have demonstrated ... more

Epigenomic changes play an important role during the progression of melanoma

KU Leuven researchers have zeroed in on what makes cancer cells in melanoma so aggressive. They also succeeded in taming the effect in cell cultures. Melanoma, a type of skin cancer, is notoriously quick to metastasize and responds poorly to existing cancer treatments. In their study, publi ... more

MyCartis Announces Appointment of Dr. Jan Groen to its Board of Directors

MyCartis NV announced that Dr. Jan Groen, an accomplished diagnostics executive, was elected to the company’s Board of Directors. Dr. Groen currently serves as president and chief executive officer of MDxHealth, a multinational healthcare company that provides actionable epigenetic informat ... more

All news on biotechnology

Aseptika Granted United States Patent for Biomarkers for Respiratory Infection Onset

Aseptika Limited announced that it has been granted a patent in the United States (US) protecting its invention for a test for respiratory infections, designed to be used by patients at home and by clinicians at the bedside of patients in hospitals. This will open up opportunities for the C ... more

Roche strengthens oncology translational research pipeline by acquiring CAPP Medical

Roche announced it has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans, to advance the development of technology for cancer screening and monitoring through the detection of circulating tumor DNA (ctDNA) in blood.  CAPP Med ... more

Bio-marker set forms the basis for new blood test to detect colorectal cancer

Colorectal cancer is the third most common form of cancer globally and the second most common cause of cancer deaths. The chance of a cure is high if the cancer is detected early enough, but early detection is not a given. Researchers from VIB and KU Leuven - together with various European ... more

Philips enters into collaboration with Janssen to develop new handheld blood test

Royal Philips announced that it has entered into a multi-year development agreement with Janssen Pharmaceutica N.V.. The collaboration aims to develop a new handheld blood test to provide doctors with a novel tool to improve the care of patients with neuropsychiatric disorders.The collabora ... more

analytica Vietnam 2015 more international than ever

This year's analytica Vietnam will have approximately 100 exhibitors from 15 countries, making it more international than ever. As part of the extensive program of related events, feature several international experts will pass on scientific background information about research and trends ... more

MDxHealth's ConfirmMDx Genes Detect Clinically Significant Prostate Cancer

MDxHealth SA announced that data demonstrating the prognostic value of its ConfirmMDx® for Prostate Cancer genes and technology was presented at the ASCO Genitourinary Cancers Symposium 2015.  The data support the ability to predict the presence of clinically significant cancer in biopsy-ne ... more

SkylineDx Appoints Oncologist as Acting as Chief Medical Officer

SkylineDx announced the appointment of Saad Usmani, MD, FACP, as their acting Chief Medical Officer.  Dr. Usmani is currently the Director of Clinical Research (Hematologic Malignancies) and Director of Plasma Cell Disorders at Carolinas HealthCare System’s Levine Cancer Institute in Charlo ... more

New screening tool could speed development of ovarian cancer drugs

University of Chicago Medicine researchers have built a model system that uses multiple cell types from patients to rapidly test compounds that could block the early steps in ovarian cancer metastasis. Their three-dimensional cell-culture system, adapted for high-throughput screening, has e ... more

Roche acquires Signature Diagnostics

Roche announced the acquisition of Signature Diagnostics AG, a privately held company based in Potsdam, Germany. Signature is a translational oncology and genomics company that develops large blood plasma and tissue biobanks in multiple cancers, including colorectal and lung, which are cons ... more

New Endoscopic Technique

Fluorescence lifetime imaging (FLIM) of tissue autofluorescence has been shown to provide labelfree contrast between different types and states of tissue. Clinical FLIM can combine lifetime contrast with morphological information to provide a direct comparison between different spatial regi ... more

All news on diagnostics

Genevac Consolidate Evaporator & Freeze Dryer Operations In Germany

Genevac has announced, as of 1st April 2015, that LMS Consult GmbH (LMS) has been appointed as the exclusive German distributor for its market leading evaporator systems plus the freeze dryer range of its parent company - SP Scientific.For over 30 years - LMS Consulthave successfully sold a ... more

Ximbio Expands Team

Ximbio announced the expansion of its team, with two new appointments. Dr Hugh Spotswood has joined as Senior Business Manager, and Emily Haggerty as a Scientific Portfolio Associate. Hugh’s role as part of Ximbio is to head up the business development function to maximise the revenue creat ... more

INTEGRA Biosciences Opens German Subsidiary

Following on from the successful launch of subsidiaries in France, the UK and the USA - INTEGRA Biosciences has announced the opening in January 2015 of a new organisation based in Konstanz, Germany.Leveraging an existing knowledgeable local sales and service team – INTEGRA Biosciences Deut ... more

TÜV SÜD explains process maturity according to the new ISO 9001

The final version of the revised standard for quality management systems is scheduled for release by the International Organisation for Standardisation (ISO) in autumn 2015. Many organisations have already started to address the expected changes, which are aimed at strengthening the benefit ... more

analytica Vietnam 2015 more international than ever

This year's analytica Vietnam will have approximately 100 exhibitors from 15 countries, making it more international than ever. As part of the extensive program of related events, feature several international experts will pass on scientific background information about research and trends ... more

Sartorius Reviews Fiscal 2014 Results

Sartorius closed fiscal 2014 with significant gains in sales revenue and earnings. At the annual press conference in Goettingen, Germany, CEO Dr. Joachim Kreuzburg stated that the Group had even slightly exceeded its financial targets and reached important milestones: "Our largest division, ... more

Sartorius: Successful Business Year 2014

Sartorius successfully closed fiscal 2014 according to its preliminary figures, and even slightly exceeded its sales revenue and earnings targets. In addition, the Group is set to further sharpen its strategic profile based on the sale of its smallest division, Industrial Technologies, whic ... more

Seward appoints Dan Crothers as Managing Director

Seward Ltd. announced the appointment of Dan Crothers as Managing Director to direct strategy and implement a series of new developments within the Company. Dan, who has worked with Seward since 2008, assumes the new role after success in previous positions, including managing Seward’s Sing ... more

Merck Obtains US Antitrust Clearance for Acquisition of Sigma-Aldrich

Merck announced that it has obtained antitrust clearance from the United States Federal Trade Commission (FTC) for its planned acquisition of US-based life science company Sigma-Aldrich. The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) in connection with i ... more

Sartorius to Sell Its Industrial Technologies Division to Minebea Co., Ltd.

Sartorius is selling its Industrial Technologies Division (Intec) to the Japanese Minebea Co., Ltd. (Minebea) and their partner, the Development Bank of Japan Inc. The respective contract was signed today. The sales price will be determined as a multiple of the Intec division’s 2014 operati ... more

All news on lab technology

Phase III Trial of the Merck and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra Leone

Merck, known as MSD outside the United States and Canada, and NewLink Genetics Corporation, confirmed that the third, late-stage, clinical trial of their Ebola vaccine candidate rVSV-ZEBOV-GP (V920) has been initiated in Sierra Leone. The vaccine candidate was originally developed by the Pu ... more

Sun Pharma and the Technion form Research Collaboration to Develop New Class of Oncology Drugs

Sun Pharmaceutical Industries Ltd. and the Technion – Israel institute of technology announced that their respective subsidiaries have entered into an exclusive worldwide research and license agreement. This agreement aims at the development of a joint project, based on new findings by Nobe ... more

Sobi receives orphan drug designation for Elocta in Switzerland

Swedish Orphan Biovitrum AB has received orphan drug designation in Switzerland for its long acting haemophilia drug candidate Elocta (rFVIIIFc) developed for the treatment of haemophilia A. An orphan drug designation is to encourage the development of medicines for rare diseases and provid ... more

Recipharm makes strategic investment in Synthonics

Recipharm announced that it has made an equity investment in Synthonics Inc and purchased $2.0 million of preferred stock in the company.A further $2.0 million of preferred stock will be purchased upon Synthonics’ achievement of certain milestones, which could be expected during 2016.  In a ... more

Pharmalink announces positive results in Phase 2b trial of Nefecon

Pharmalink AB announced that the NEFIGAN Trial of Nefecon® for the treatment of primary IgA nephropathy has fully met its primary efficacy endpoint at a planned interim analysis and been stopped early with respect to statistical analysis of the endpoint. The NEFIGAN Trial is a Phase 2b rand ... more

LDC and AstraZeneca broaden Drug Discovery Alliance

The Lead Discovery Center GmbH (LDC) and AstraZeneca have expanded their alliance to discover new medicines for the treatment of human diseases with high unmet medical need. Through an additional three-year period of collaboration, AstraZeneca will provide an extended set of high-quality co ... more

Cipher Pharmaceuticals acquires INNOCUTIS Holdings

Onxeo S.A. announced Cipher Pharmaceuticals' acquisition of INNOCUTIS Holdings LLC, the licensee of Sitavig® in the USA. As a major step in the growth strategy of Cipher Pharmaceuticals, this acquisition provides Cipher with a commercial infrastructure and a talented sales team for the USA. ... more

Merck Appoints Udit Batra to Head Combined Life Science Business

Merck announced that Udit Batra, currently CEO and President of Merck Millipore, has been appointed to lead the combined life science business of Merck Millipore and Sigma-Aldrich once the acquisition of Sigma-Aldrich has been successfully completed. The planned $ 17 billion transaction rem ... more

AOP Orphan and Rigi Healthcare Start Rigi Orphan Inc., USA

AOP Orphan Pharmaceuticals AG and Rigi Healthcare AG announced the creation of Rigi Orphan Inc, USA.  The new company will focus on the development, in-licensing and commercialization of pharmaceutical specialties for rare diseases in North America.„We are proud to continue our expansion st ... more

Santhera receives FDA Fast Track Designation for Raxone/Catena (idebenone)

Santhera Pharmaceuticals announces that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Santhera's Raxone®/Catena® (idebenone) for the treatment of Duchenne Muscular Dystrophy (DMD). FDA's Fast Track program facilitates the development and review of import ... more

All news on pharma

A new tool for understanding ALS: Patients' brain cells

Researchers at Johns Hopkins Medicine have transformed skin cells from patients with Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS), into brain cells affected by the progressive, fatal disease and deposited those human-made cells into the first public ALS cell library, enablin ... more

ThromboGenics and VIB launch New Oncology Company

ThromboGenics NV announced the foundation of Oncurious NV, a new oncology company that will develop TB-403 for the treatment of pediatric brain tumors. VIB will become a shareholder alongside ThromboGenics in this new oncology venture. ThromboGenics will be the majority shareholder. TB-403 ... more

How can a microwave save a frostbitten rabbit?

Cases of frostbite account for about 10% of all trauma cases seen in the northern regions of Russia. Treatment can last for two or more months, and almost 90% of these injuries result in disability. However, Tomsk University scientists believe that in many cases the treatment process can be ... more

Brain training instead of medication to counter insomnia

The ability to finally enjoy a good night's sleep is something that can be learned. An Austrian Science Fund FWF project has investigated how this can best be learned and who responds best to such "brain training". Dark circles around the eyes, tired limbs, absent-mindedness – most people ... more

Enzyme in cosmetic products can act as allergen via the skin

Papain is found naturally in papaya and is often referred to as a "plant-based pepsin" in reference to the digestive enzyme pepsin that is present in the stomach. Erika Jensen-Jarolim, Head of the Department of Comparative Medicine at the Messerli Research Institute, and her team researched ... more

HIV spreads like internet malware and should be treated earlier

A new model for HIV progression finds that it spreads in a similar way to some computer worms and predicts that early treatment is key to staving off AIDS.HIV specialists and network security experts at UCL noticed that the spread of HIV through the body using two methods - via the bloodstr ... more

Epigenomic changes play an important role during the progression of melanoma

KU Leuven researchers have zeroed in on what makes cancer cells in melanoma so aggressive. They also succeeded in taming the effect in cell cultures. Melanoma, a type of skin cancer, is notoriously quick to metastasize and responds poorly to existing cancer treatments. In their study, publi ... more

A new piece in the 'French paradox' puzzle

Figuring out why the French have low cardiovascular disease rates despite a diet high in saturated fats has spurred research and many theories to account for this phenomenon known as the "French paradox." Most explanations focus on wine and lifestyle, but a key role could belong to another ... more

In the sea, a deadly form of leukemia is catching

Outbreaks of leukemia that have devastated some populations of soft-shell clams along the east coast of North America for decades can be explained by the spread of cancerous tumor cells from one clam to another. Researchers call the discovery, reported in the Cell, "beyond surprising.""The ... more

Stanford-led study finds limited mutations involved in transmission of drug-resistant HIV

In the largest study of its kind to date, researchers at Stanford University School of Medicine and their colleagues have found that worldwide only a limited number of mutations are responsible for most cases of transmission of drug-resistant HIV. HIV, the virus that causes AIDS, can mutate ... more

All news on healthcare
News by department
News according to country
Companies in the news
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE
?>